UnitedHealth under federal investigation, company reveals in filing.

UnitedHealth Group has confirmed that it is currently the subject of both criminal and civil investigations by the Department of Justice. The company announced these developments in a recent filing with the Securities and Exchange Commission. UnitedHealth made it clear that they are fully cooperating with the requests from the DOJ and are committed to working closely with them as the process unfolds.

The investigations were initiated after the company reached out to the DOJ after reports in the media surfaced regarding a probe into their Medicare practices. Despite the ongoing investigations, UnitedHealth expressed confidence in their practices, stating that they have been maintaining the integrity of their business practices. The company emphasized its commitment to being responsible stewards of American tax dollars.

This news comes amidst a challenging period for UnitedHealth Group, the largest healthcare company in the United States. The company has encountered several setbacks in recent times, including the tragic incident involving the fatal shooting of UnitedHealthcare CEO Brian Thompson last year in New York. This event drew significant attention and sparked a national conversation about the frustrations people have with healthcare providers.

Furthermore, UnitedHealth Group faced turmoil earlier this year when their CEO departed abruptly in May. Following this leadership change, the company’s stock price experienced a decline, exacerbated by reports in The Wall Street Journal detailing civil and criminal investigations into various aspects of the company’s operations. The investigations included a probe by the DOJ’s healthcare-fraud unit into potential Medicare fraud, as well as scrutiny of antitrust violations and Medicare billing practices.

As a result of these ongoing challenges, UnitedHealth Group was the worst-performing stock on the Dow Jones Industrial Average in the first half of 2025. The company’s stock price took a hit, dropping by 1.5 percent in morning trading after the announcement of the federal investigations. Amidst these difficulties, the company remains focused on upholding high standards in its operations and navigating the legal proceedings with transparency and cooperation.

Despite the gravity of the situation, UnitedHealth remains steadfast in their commitment to working collaboratively with the Department of Justice. The company’s proactive approach in addressing the investigations demonstrates their dedication to resolving any concerns raised by the regulators. The Department of Justice is yet to provide further details or comments on the investigations as they continue to unfold.

In conclusion, UnitedHealth Group’s disclosure of a federal investigation underscores the complexities and challenges faced by even the largest healthcare companies in the country. The company’s response to the investigations, including its commitment to cooperation and transparency, will be pivotal in shaping the outcomes of these inquiries. As the situation evolves, UnitedHealth remains focused on maintaining its integrity and serving the best interests of its stakeholders and the broader public.